Skip to Main Content

Paper Details

Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies.
Neurooncol Adv
2
2022
BM, CACNA2D2, CNSL, GAP43, GBM, TFF3, blood-brain barrier disruption, brain malignancies, brain metastases, glioblastoma, intra-axial brain tumors, intra-axial malignancies, nervous system lymphoma, single, single cell RNA, tumor
Author NameAffiliation
Gelareh ZadehPrincess Margaret Cancer Centre, University Health Network and University of Toronto
Gelareh ZadehUniversity of Toronto
Jason MoffatUniversity of Toronto
Jason MoffatInstitute for Biomedical Engineering, University of Toronto
Jason MoffatUniversity of Toronto
Thomas KislingerPrincess Margaret Cancer Centre
Thomas KislingerUniversity of Toronto
Thomas KislingerPrincess Margaret Cancer Centre
Thomas KislingerUniversity of Toronto
  • 1 - 9

Datasets

Release 1.2